VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | Bintrafusp alfa in MSI-H cancers following progression on immunotherapy

Arvind Dasari, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses an ongoing Phase II study evaluating bintrafusp alfa in patients with metastatic microsatellite-high (MSI-H) cancers following progression on immunotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter